WHO. WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020. 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020. Accessed 14 Jan 2021
WHO. WHO Coronavirus (COVID-19) Dashboard. 2021. https://covid19.who.int/. Accessed 11 Dec 2021
Chen L, Cai J, Lin Q, Xiang B, Ren T. Imported COVID-19 cases pose new challenges for China. J Infect. 2020;80(6):e43–4.
Pan J, Tian J, Xiong H, Liu Z, Yao Y, Wang Y, Zhu W, Wang Y, Wang W. Risk assessment and evaluation of China’s policy to prevent COVID-19 cases imported by plane. PLoS Negl Trop Dis. 2020;14(12): e0008908.
Wenjie T, Peihua N, Xiang Z, Yang P, Yong Z, Lijuan C, Li Z, Yanhai W, Dayan W, Jun H, et al. Reemergent Cases of COVID-19 — Xinfadi Wholesales Market, Beijing Municipality, China, June 11, 2020. China CDC Weekly. 2020;2(27):502–4.
Cao C, Hemuti M, Zhiyuan J, Xiang Z, Dayan W, Jun Z, Zhenguo G, Peipei L, Yang S, Zhixiao C, et al. Reemergent Cases of COVID-19 — Xinjiang Uygur Autonomous Region, China, July 16, 2020. China CDC Weekly. 2020;2(39):761–3.
Xiang Z, Lingling M, Jianqun Z, Yong Z, Yang S, Zhijian B, Hong W, Ji W, Cao C, Jinbo X, et al. Reemergent Cases of COVID-19 — Dalian City, Liaoning Province, China, July 22, 2020. China CDC Weekly. 2020;2(34):658–60.
Shanghai Municipal Health Commission. 2021. https://wsjkw.sh.gov.cn/. Accessed 10 Dec 2021
Zhu W, Zhang M, Pan J, Yao Y, Wang W. Effects of prolonged incubation period and centralized quarantine on the COVID-19 outbreak in Shijiazhuang, China: a modeling study. BMC Med. 2021;19(1):308.
Xiangyu Y, Litao C, Zekun W, Linhui H, Zhongwei J, Bo Z, Tiejun S. Exploring the Bridge Cases’ Role in the Transmission of the SARS-CoV-2 Delta Variant — Ruili City, Yunnan Province, China, July–September 2021. China CDC Weekly. 2021;3(50):1065–70.
Zhu W, Zhu Y, Wen Z, Zheng B, Xu A, Yao Y, Wang W. Quantitative assessment of the effects of massive nucleic acid testing in controlling a COVID-19 outbreak. BMC Infect Dis. 2022;22(1):845.
National Health Commission of the People's Republic of China. The latest COVID-19 situation as of 24:00 On 10 December. 2021. http://www.nhc.gov.cn/xcs/yqfkdt/202112/950ec08b21c3460bb710b19e50ee37ec.shtml. Accessed 11 Dec 2021
National Medical Products Administration. China grants conditional approval for first COVID vaccine. 2020. http://english.nmpa.gov.cn/2020-12/31/c_579192.htm. Accessed 5 Apr 2021
The State Council, The People's Republic of China. Chinese COVID-19 vaccines free to all its citizens: official. 2020. http://english.www.gov.cn/statecouncil/ministries/202012/31/content_WS5fed9059c6d0f72576942e9e.html. Accessed 6 Apr 2021
National Health Commission of the People's Republic of China. COVID-19 vaccination status. 2021. http://www.nhc.gov.cn/xcs/yqfkdt/202112/b745eb101a314b6397be543d7492f0c8.shtml. Accessed 10 Dec 2021
WHO. Weekly epidemiological update on COVID-19 - 7 December 2021. 2021. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports. Accessed 11 Dec 2021
Li XN, Huang Y, Wang W, Jing QL, Zhang CH, Qin PZ, Guan WJ, Gan L, Li YL, Liu WH, et al. Effectiveness of inactivated SARS-CoV-2 vaccines against the Delta variant infection in Guangzhou: a test-negative case-control real-world study. Emerg Microbes Infect. 2021;10(1):1751–9.
Sandmann FG, Davies NG, Vassall A, Edmunds WJ, Jit M. Centre for the Mathematical Modelling of Infectious Diseases C-wg: The potential health and economic value of SARS-CoV-2 vaccination alongside physical distancing in the UK: a transmission model-based future scenario analysis and economic evaluation. Lancet Infect Dis. 2021;67:9.
Coudeville L, Jollivet O, Mahe C, Chaves S, Gomez GB. Potential impact of introducing vaccines against COVID-19 under supply and uptake constraints in France: A modelling study. PLoS ONE. 2021;16(4): e0250797.
Moore S, Hill EM, Tildesley MJ, Dyson L, Keeling MJ. Vaccination and non-pharmaceutical interventions for COVID-19: a mathematical modelling study. Lancet Infect Dis. 2021;34:56.
Health Commission of Guizhou. Notification on the investigation of the COVID-19 case in the Huichuan District, Zunyi City, Guizhou Province. 2021. http://wjw.guizhou.gov.cn/ztzl_500663/xxgzbdgrdfyyqfk/yqdt/202110/t20211019_70933984.html. Accessed 2 Nov 2021
Health Commission of Guizhou. Zunyi city announced that nucleic acid testing will be carried out in three times in the central city. 2021. http://wjw.guizhou.gov.cn/xwzx_500663/zwyw/202110/t20211023_71118693.html. Accessed 2 Nov 2021
Hellewell J, Abbott S, Gimma A, Bosse NI, Jarvis CI, Russell TW, Munday JD, Kucharski AJ, Edmunds WJ, et al. Feasibility of controlling COVID-19 outbreaks by isolation of cases and contacts. Lancet Glob Health. 2020;8(4):e488–96.
Health Commission of Guizhou. 2021. http://wjw.guizhou.gov.cn/. Accessed 2 Nov 2021
Zhang WT, Liu D, Xie CJ, Shen D, Chen ZQ, Li ZH, Liu Y, Zhang XR, Chen PL, Zhong WF, et al. Sensitivity and specificity of nucleic acid testing in close contacts of COVID-19 cases in Guangzhou. Zhonghua Liu Xing Bing Xue Za Zhi. 2021;42(8):1347–52.
Meng Z, Jianpeng X, Aiping D, Yingtao Z, Yali Z, Ting H, Jiansen L, Hongwei T, Bosheng L, Yan Z, et al. Transmission Dynamics of an Outbreak of the COVID-19 Delta Variant B.1.617.2—Guangdong Province, China, May–June 2021. China CDC Weekly. 2021;3(27):584–6.
Davies NG, Abbott S, Barnard RC, Jarvis CI, Kucharski AJ, Munday JD, Pearson CAB, Russell TW, Tully DC, Washburne AD, et al. Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England. Science. 2021;372:6538.
He X, Lau EHY, Wu P, Deng X, Wang J, Hao X, Lau YC, Wong JY, Guan Y, Tan X, et al. Temporal dynamics in viral shedding and transmissibility of COVID-19. Nat Med. 2020;26(5):672–5.
Team RC, R: A Language and Environment for Statistical Computing. (Vienna, Austria). https://www.R-project.org/.
Venables WN, Ripley BD. Modern Applied Statistics with S, vol. Fourth. New York: Springer; 2002.
Homma Y, Katsuta T, Oka H, Inoue K, Toyoshima C, Iwaki H, Yamashita Y, Shinomiya H. The incubation period of the SARS-CoV-2 B117 variant is shorter than that of other strains. J Infect. 2021;83(2):e15–7.
Hodgson SH, Mansatta K, Mallett G, Harris V, Emary KRW, Pollard AJ. What defines an efficacious COVID-19 vaccine? A review of the challenges assessing the clinical efficacy of vaccines against SARS-CoV-2. Lancet Infect Dis. 2020;78:56.
Pan J, Zhu W, Tian J, Liu Z, Xu A, Yao Y, Wang W. Vaccination as an alternative to non-drug interventions to prevent local resurgence of COVID-19. Infect Dis Poverty. 2022;11(1):36.
Li Z, Liu F, Cui J, Peng Z, Chang Z, Lai S, Chen Q, Wang L, Gao GF, Feng Z. Comprehensive large-scale nucleic acid-testing strategies support China’s sustained containment of COVID-19. Nat Med. 2021;27(5):740–2.
Cheng W, Zhao N, Qin Y, Tian J, Huang Y. Mass testing to support sustained containment of COVID-19. J Glob Health. 2021;11:03114.
Davis EL, Lucas TCD, Borlase A, Pollington TM, Abbott S, Ayabina D, Crellen T, Hellewell J, Pi L, et al. Contact tracing is an imperfect tool for controlling COVID-19 transmission and relies on population adherence. Nat Commun. 2021;12(1):5412.
Churches T, Jorm L. Flexible, Freely Available Stochastic Individual Contact Model for Exploring COVID-19 Intervention and Control Strategies: Development and Simulation. JMIR Public Health Surveill. 2020;6(3): e18965.